T H E N I H C A T A L Y S T | M A Y J U N E 2008 |
|
F R O M | T H E | D E P U T Y | D I R E C T O R | F O R | I N T R A M U R A L | R E S E A R C H |
NIH DIRECTOR'S INTRAMURAL CHALLENGE AWARDS
![]() |
Michael Gottesman |
By the time you read this, my office
will
have
announced a request for applications
for a new source of intramural funding: the NIH Director’s Intramural Challenge
Awards.
Dr.
Zerhouni has provided $1.5 million in new intramural funds to stimulate highly
innovative, potentially high-impact research.
The
awards seek to bring together researchers from multiple institutes and centers
(ICs), who will take advantage of the strengths and unique aspects of the NIH
intramural program.
This year the funds will support
projects related to the three existing trans-NIH initiatives—the Center
for Human Immunology, Autoimmunity, and Inflammation (CHI), the Imaging
Initiative (Molecules to Cells), and the Systems Biology Initiative (Molecular
Networks).
Funds will be awarded in mid-July,
and must be spent by September 30, 2008.
Beginning October 1, 2008, we will
expand the program.
First, we will solicit ideas for additional programmatic
topics, and new areas of interest will be selected. The intent here is to
broaden the trans-NIH initiatives beyond Immunology, Systems Biology, and
Imaging to new areas of potential trans-NIH cooperation.
We will cast a wide net among all of
our investigators for subject areas that are well-matched to the talents,
environment, and resources in the intramural program.
The scientific directors will choose
the topics from among the nominations received from our faculty. Then, senior
investigators and investigators can apply for funds, with approval of their
scientific directors, to support projects related to one of the newly selected
topics, or to one of the three current trans-NIH initiatives.
Awards will be made for up to two
years of funding, and can be used to support personnel, equipment, and/or
supplies.
Requests should be in the range of
$50,000–$200,000 per year. Preference will be given to proposals that bring together two or more
ICs, but the major emphasis will be on highly innovative, potentially
high-impact research.
Our hope is that your scientific
directors will use this opportunity to invest in projects that would have been
difficult to support without these new funds.
In reviewing the current budget
situation, it has become clear that declining budgets have taken their toll on
NIH intramural equipment and supply funds, and many of our laboratories are
having trouble purchasing cutting-edge equipment and expensive reagents.
For work that can create new fields or make paradigm-shifting
contributions to existing fields—and that takes advantage of trans-NIH
collaborations—we hope that these NIH Director’s Intramural Challenge Awards
can make a difference.
The Office of Intramural Research is
in the process of creating a website that lists other sources of trans-NIH
funds that are competitive and bring new resources into your IC and your lab,
including the Intramural AIDS Targeted Anti-Viral Program, the NIAID Biodefense
Program, the Clinical Center Bench-to-Bedside Program, and several NIH training
and education programs. We’ll let you know when this website is activated.
As always, your comments on these
new initiatives are welcome.
—Michael
Gottesman
Deputy
Director for Intramural Research